Condition: Adrenocortical Tumor · Sponsor: St. Jude Children's Research Hospital
This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide. In addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.
This description comes directly from the study's public registry record.
Raul C Ribeiro, MD · 866-278-5833 · referralinfo@stjude.org
Always discuss trial participation with your own doctor first.
| Stanford University | Stanford, California, United States | Completed |
| All Children's Hospital/St. Petersburg Hospital | St. Petersburg, Florida, United States | Completed |
| The Children's Medical Center | Dayton, Ohio, United States | Recruiting |
| St. Jude Children's Research Hospital | Memphis, Tennessee, United States | Recruiting |
| Cook Children's Medical Center | Fort Worth, Texas, United States | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00700414